Cytokine and cytokine-modulating therapies have demonstrated tremendous efficacy against cancers and in inflammatory diseases. These disorders are particularly prevalent at epithelial barrier sites such as the skin, gut, and lung. Our symposium showcases exciting advances on how cytokines maintain health and provoke disease in barrier tissues by bringing together leaders from different disease areas including inflammatory bowel disease, psoriasis, atopic diseases, neurological diseases and cancers. We highlight how cytokines dynamically control immune cell development and function. In addition, our featured speakers are pioneering efforts to understand the mechanisms by which cytokines facilitate dialogue between immune and non-immune cells and the profound consequences for disease predilection and pathology. Such interdisciplinary discussions will shed light on next-generation therapies to modulate both cytokines and their cellular targets.
Organizing Society International Cytokine and Interferon Society
Session Chairs Shruti Naik, PhD Brian Kim MD, PhD
Session Agenda 1:30 PM - 1:35 PM Opening Shruti Naik, PhD Grossman School of Medicine
Brian Kim MD, PhD Mt Sinai School of Medicine
1:35 PM - 1:55 PM Niroshana Anandasabapathy, MD, PhD Weill Cornell Medical College